CAS 122852-69-1
:Alosetron hydrochloride
Description:
Alosetron hydrochloride is a selective serotonin 5-HT3 receptor antagonist primarily used in the treatment of irritable bowel syndrome (IBS) in women with severe symptoms. It works by modulating the activity of serotonin in the gastrointestinal tract, thereby reducing bowel motility and alleviating symptoms such as abdominal pain and diarrhea. The compound is characterized by its hydrochloride salt form, which enhances its solubility and stability. Alosetron is typically administered orally and is known for its efficacy in managing IBS, although it is associated with potential side effects, including constipation and, in rare cases, serious gastrointestinal complications. Due to these risks, its use is restricted and monitored in clinical settings. The chemical structure of alosetron includes a fused indole ring system, contributing to its pharmacological properties. As with any medication, it is essential to consider patient-specific factors and potential drug interactions when prescribing alosetron hydrochloride.
Formula:C17H18N4O·ClH
InChI:InChI=1S/C17H18N4O.ClH/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2;/h3-6,10H,7-9H2,1-2H3,(H,18,19);1H
InChI key:InChIKey=FNYQZOVOVDSGJH-UHFFFAOYSA-N
SMILES:O=C1C=2C=3C(N(C)C2CCN1CC4=C(C)N=CN4)=CC=CC3.Cl
Synonyms:- 1H-Pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-, hydrochloride (1:1)
- 1H-Pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-, monohydrochloride
- 2,3,4,5-Tetrahydro-5-Methyl-2-[(5-Methyl-1H-Imidazol-4-Yl)Methyl]-1H-Pyrido[4,3-B]Indol-1-One Hydrochloride
- 2,3,4,5-Tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-1H-pyrido[4,3-b]indol-1-one Hydrochloride
- 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one hydrochloride (1:1)
- Alosetron Hcl
- Gr 68755C
- Gr 68755X
- Alosetron hydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Alosetron Hydrochloride
CAS:Formula:C17H18N4O·HClPurity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:330.82Alosetron Hydrochloride (2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride)
CAS:Lactams not elsewhere specified or includedFormula:C17H18N4O·HClColor and Shape:White Beige SolidMolecular weight:330.12474Alosetron hydrochloride
CAS:<p>Alosetron hydrochloride (GR 68755), a selective 5-HT3 receptor antagonist, can block the actions of serotonin at 5-HT3 sites in the peripheral nervous system.</p>Formula:C17H19ClN4OPurity:99.90%Color and Shape:Off-White PowderMolecular weight:330.81Alosetron (hydrochloride)
CAS:Formula:C17H19ClN4OPurity:97%Color and Shape:SolidMolecular weight:330.8120Alosetron Hydrochloride
CAS:Controlled ProductFormula:C17H18N4O·ClHColor and Shape:NeatMolecular weight:330.81Alosetron HCl - Bio-X ™
CAS:Controlled Product<p>Alosetron is a serotonin 5-HT3 receptor antagonist that is used for the treatment and management of severe diarrhoea- predominant irritable bowel syndrome. The regulation of processes connected to IBS such as visceral discomfort, colonic transit, and GI secretions is impacted by the activation of the 5-HT3 receptors and resulting neuronal depolarization. Alosetron manages IBS by inhibiting these receptors.</p>Formula:C17H18N4O•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:330.81 g/molAlosetron HCl
CAS:Controlled Product<p>Serotonin 5-HT3 receptor antagonist</p>Formula:C17H19ClN4OPurity:Min. 95%Color and Shape:White Slightly Brown PowderMolecular weight:330.81 g/molAlosetron Hydrochloride
CAS:Controlled Product<p>Applications Serotonin 5HT3-receptor antagonist. Used in treatment of irritable bowel syndrome.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Camilleri, M., et al.: Lancet, 355, 1035 (2000), Nestorov, I., et al.: Drug Metab. Dispos., 30, 276 (2002), Lewis, D., et al.: Drug Metab. Rev., 35, 1 (2003), Tang, H., et al.: J. Pharm. Sci., 95, 1783 (2006), Gleeson, M., et al.: J. Med. Chem., 50, 101 (2007),<br></p>Formula:C17H18N4O·ClHColor and Shape:NeatMolecular weight:330.81









